Kempner Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.47M Sell
2,327
-193
-8% -$185K 2.34% 22
2025
Q3
$1.92M Buy
+2,520
New +$1.88M 1.6% 30

Other funds holding LLY

Kempner Capital Management's LLY Position: Q4 2025 in Review

Kempner Capital Management reduced its Eli Lilly (LLY) stake by 7.7% in Q4 2025, selling an estimated $185K and leaving 2,327 shares worth $2.47M. The position accounts for 2.34% of the portfolio, ranked #22.

Kempner Capital Management first reported a position in LLY in Q3 2025 and has held it in 2 quarters since. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Kempner Capital Management held 2,327 shares of Eli Lilly worth $2.47M as of Q4 2025.
  • Kempner Capital Management sold 193 Eli Lilly shares in Q4 2025, an estimated $185K.
  • Eli Lilly made up 2.34% of Kempner Capital Management's portfolio in Q4 2025, its #22 holding.
  • Kempner Capital Management first reported a position in Eli Lilly in Q3 2025 and has held it in 2 quarters since.
  • 4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Kempner Capital Management's 13F filing for Q4 2025, filed 12 Jan 2026.